Le Marché des Antipaludéens: Entre Régulation et Défaillance

Fabienne Orsi and Jean-Benoit Zimmermann
Additional contact information
Fabienne Orsi: SESSTIM - U912 INSERM - Aix Marseille Univ - IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale - IRD - Institut de Recherche pour le Développement - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale, GREQAM - Groupement de Recherche en Économie Quantitative d'Aix-Marseille - EHESS - École des hautes études en sciences sociales - AMU - Aix Marseille Université - ECM - École Centrale de Marseille - CNRS - Centre National de la Recherche Scientifique

Working Papers from HAL

Abstract: Faced with the rise of resistance to monotherapies, the artemisinine-combination therapies (ACTs) have become the early 2000s, the golden standard in the fight against plasmodium falciparum malaria. Because of the need to substitute these therapies to older drugs and given the vastly more expensive ACTs, WHO has established itself in global prescriber, enacting, on the one hand, health policy recommendations towards the endemic countries and organizing, on the other, a global supply chain. This article analyzes the disconnect that results from this model of governance, between the national and global levels and the consequences on the health status of malarious countries.

Keywords: malaria; artemisinin; ACT; global governance; health policies; financing; price; intellectual property; paludisme; atémisinine; CTA; gouvernance mondiale; politiques sanitaires; production; financement; prix; propriété intellectuelle (search for similar items in EconPapers)
Date: 2014-11
New Economics Papers: this item is included in nep-ger
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-01091331v1
References: Add references at CitEc
Citations:

Downloads: (external link)
https://shs.hal.science/halshs-01091331v1/document (application/pdf)

Related works:
Journal Article: Le marché des antipaludéens, entre régulation et défaillance (2015)
Working Paper: Le marché des antipaludéens: entre régulation et défaillance (2015)
Working Paper: Le Marché des Antipaludéens: Entre Régulation et Défaillance (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:wpaper:halshs-01091331

Access Statistics for this paper

More papers in Working Papers from HAL
Bibliographic data for series maintained by CCSD ().